Percutaneous Nephrolithotomy System Market Size & Growth Analysis to 2030

The global percutaneous nephrolithotomy system market was valued at over USD 0.5 billion in 2022 and expected to grow at a significant CAGR of around 5% during the forecast period from 2023 to 2030. The market is driven by several factors, including the increasing prevalence of kidney stones, rising demand for minimally invasive surgical procedures, and technological advancements in the field of urology. Kidney stones are a common urological disorder affecting millions of people globally, leading to high demand for treatment options. Percutaneous nephrolithotomy (PCNL) is a minimally invasive surgical procedure used to remove kidney stones, and it has gained popularity due to its high success rates and fewer complications.

Additionally, advancements in the percutaneous nephrolithotomy system have improved its safety and efficacy, making it a preferred treatment option for patients with complex and large kidney stones. The development of new devices and instruments with better visualization, such as fiber-optic flexible nephroscopes, digital imaging systems, and lithotripters, have significantly enhanced the precision and effectiveness of the procedure.

Moreover, the growing awareness about the advantages of percutaneous nephrolithotomy over other surgical procedures, such as open surgery and extracorporeal shock wave lithotripsy, has further propelled market growth. The benefits of PCNL include a shorter hospital stay, less pain, fewer complications, and a quicker recovery time, making it a cost-effective option for patients and healthcare providers.

Furthermore, increasing investments in research and development activities by key market players to introduce advanced and innovative percutaneous nephrolithotomy systems are expected to drive the market further. The rising prevalence of kidney stones and the increasing adoption of minimally invasive surgical procedures are expected to continue driving the growth of the percutaneous nephrolithotomy system market in the coming years.

Market Drivers:

Increasing prevalence of kidney stones: The growing incidence of kidney stones among the population is one of the major driving factors for the percutaneous nephrolithotomy system market. According to the National Kidney Foundation, about one in ten people will have a kidney stone at some point in their lives, with the highest incidence occurring in people aged 20 to 40.

Technological advancements: Advancements in percutaneous nephrolithotomy technology, including the development of miniaturized devices, improved imaging modalities, and the use of robotics, have improved the efficacy and safety of the procedure, leading to increased adoption by healthcare providers.

Increasing demand for minimally invasive procedures: The rising demand for minimally invasive procedures, which offer reduced postoperative pain, shorter hospital stays, and faster recovery times compared to traditional open surgery, is another driving factor for the percutaneous nephrolithotomy system market.

Growing geriatric population: The geriatric population is more susceptible to kidney stones, and with the aging of the global population, the demand for percutaneous nephrolithotomy systems is expected to increase.

Increasing healthcare expenditure: Rising healthcare expenditure in both developed and developing countries is expected to increase the adoption of percutaneous nephrolithotomy systems. Additionally, favorable reimbursement policies in some countries for the treatment of kidney stones are also expected to drive market growth.

Market Snapshot:

To know more about the research study, request sample papers

Market Insights:

Global Percutaneous Nephrolithotomy Systems Market Analysis by Type:

The percutaneous nephrolithotomy systems market is bifurcated into product type, end-use, and geography. The market can be analyzed by product type, with the following major segments: Micro-percutaneous nephrolithotomy, Ultra-mini percutaneous nephrolithotomy, and Mini percutaneous nephrolithotomy. The dominant segment in the market is likely to be micro-PCNL, as it has been widely adopted and has demonstrated safety and efficacy in clinical studies. However, as UMP gains popularity, it may begin to challenge the dominance of micro-PCNL in the market.

Micro-percutaneous nephrolithotomy (micro-PCNL) is a minimally invasive procedure that uses a small diameter instrument to remove kidney stones. It is considered less invasive than traditional PCNL and has a lower risk of complications. The use of micro-PCNL has been increasing in recent years due to its improved safety and efficacy compared to other procedures.

Ultra-mini percutaneous nephrolithotomy (UMP) is a newer technique that uses an even smaller diameter instrument than micro-PCNL. This technique is designed to be even less invasive and has shown promising results in clinical studies. As a result, UMP is gaining popularity and is expected to drive growth in the percutaneous nephrolithotomy systems market.

Mini percutaneous nephrolithotomy (mini-PCNL) is a variation of traditional PCNL that uses a smaller diameter instrument. It is considered less invasive than traditional PCNL but more invasive than micro-PCNL and UMP. However, mini-PCNL is still a commonly used technique for the treatment of kidney stones, particularly for larger stones.

Global Percutaneous Nephrolithotomy Systems Market by End-Use:

On the basis of end-use, the percutaneous nephrolithotomy systems market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. Among these, hospitals are the dominant segment in the market, accounting for a significant share of the market revenue. This can be attributed to the increasing prevalence of kidney stones and the availability of skilled healthcare professionals and advanced healthcare infrastructure in hospitals.

Additionally, hospitals offer a range of services related to the diagnosis and treatment of kidney stones, which further drives their demand for percutaneous nephrolithotomy systems. Specialty clinics and ambulatory surgical centers also contribute to the market growth, owing to their advantages such as reduced healthcare costs and shorter hospital stays. The increasing trend of outpatient surgeries and minimally invasive procedures is expected to further boost the demand for percutaneous nephrolithotomy systems in these end-use segments.

The percutaneous nephrolithotomy system market research report presents the analysis of each segment from 2020 to 2030 considering 2022 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2023 to 2030.

Historical & Forecast Period

• 2020-21 – Historical Year
• 2022 – Base Year
• 2023-2030 – Forecast Period

Market Segmentation:

By Product Type:

• Micro-Percutaneous Nephrolithotomy
• Ultra-Mini Percutaneous Nephrolithotomy
• Mini Percutaneous Nephrolithotomy

By End-Use:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Geographic Coverage:

Geographically, the percutaneous nephrolithotomy system market report comprises dedicated sections centering on the regional market revenue and trends. The percutaneous nephrolithotomy system market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The percutaneous nephrolithotomy system market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. Percutaneous nephrolithotomy system market estimates have also been provided for the historical years 2020 & 2021 along with forecasts for the period from 2023 – 2030.

Competitive Assessment:

Some of the major market players operating in the global percutaneous nephrolithotomy system market are Boston Scientific Corporation, Cook Medical, Olympus Corporation, Richard Wolf GmbH, and Electro Medical Systems SA. The new developments indicate a focus on improving efficiency, reducing procedural time, and enhancing visualization and control during percutaneous nephrolithotomy procedures, ultimately leading to better outcomes for patients. For instance:

• In 2021, Olympus launched its new Soltive SuperPulsed Laser System, which is designed to enhance surgical outcomes and reduce procedural time during percutaneous nephrolithotomy procedures. The system uses advanced laser technology to optimize energy delivery and improve stone fragmentation.
• In 2021, Cook Medical launched its PercuFuse System, which is designed to simplify the process of administering contrast media during percutaneous nephrolithotomy procedures. The system features a pre-loaded syringe and an easy-to-use connector, making it faster and easier to use.
• In 2021, Stryker Corporation acquired Gauss Surgical, a developer of artificial intelligence-enabled software solutions for blood loss monitoring during surgery, including percutaneous nephrolithotomy procedures. This acquisition is expected to enhance Stryker’s offerings in the field of surgical visualization and analytics.
• In 2020, Boston Scientific launched its LithoVue Empower Retrieval Deployment Device, which is designed to retrieve kidney stones during percutaneous nephrolithotomy procedures. The device offers improved visualization and control, making the retrieval process more efficient.

Key Companies:

• Boston Scientific Corporation
• Cook Medical
• Olympus Corporation
• Richard Wolf GmbH
• Electro Medical Systems SA
• Stryker Corporation
• KARL STORZ SE & Co. KG
• ROCAMED
• Medtronic
• Convergent Laser Technologies
• Lumenis

Key Questions Answered by Percutaneous Nephrolithotomy System Market Report

• Global percutaneous nephrolithotomy system market forecasts from 2023-2030
• Regional market forecasts from 2023-2030 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
• Country-level forecasts from 2023-2030 covering 15 major countries from the regions as mentioned above
• Percutaneous nephrolithotomy system submarket forecasts from 2023-2030 covering the market by product type, end-use, and geography
• Various industry models such as SWOT analysis, Value Chain Analysis about the market
• Analysis of the key factors driving and restraining the growth of the global, regional, and country-level percutaneous nephrolithotomy system markets from 2023-2030
• Competitive Landscape and market positioning of the top 10 players operating in the market